LONDON--(BUSINESS WIRE)--The global erectile dysfunction (ED) drugs market size is poised to decline by USD 575.07 million during 2019-2023, according to a new report by Technavio, decelerating at a CAGR of more than 4% during the forecast period.
Read the 120-page research report with TOC on " Erectile Dysfunction (ED) Drugs Market Analysis Report by product (oral drugs, topical drugs, and others) and geography (North America, Europe, Asia, and ROW) 2019 - 2023" at: Request a Free Sample Report
The market is driven by the high prevalence of conditions resulting in ED. Also, the rising demand for ED drugs to further boost the growth of the erectile dysfunction (ED) drugs market.
Various health conditions, including diabetes, hypertension, obesity, depression, stress, and excessive alcohol consumption, are resulting in the rising incidence of ED among the elderly as well as young people. As these conditions directly alter the normal physiological levels of hormones, enzymes, and other factors, problems including penile erection have surged considerably in recent years. These issues will further boost the erectile dysfunction drugs market to register significant growth in the forthcoming years.
Another key driver that is expected to boost the growth of the global erectile dysfunction (ED) drugs market is the rise in demand for ED drugs. The rise in cyber pornography and the increasing number of advertisements for the treatment of ED are also expected to propel the demand for erectile dysfunction (ED) drugs during the forecast period.
For More Information: Speak to an Analyst
The report includes detailed profiles of the leading companies & prominent vendors of the market:
- Bayer AG
- Eli Lilly and Company
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- VIVUS Inc.
Market Segmentation by Product:
The erectile dysfunction (ED) drugs market can be broadly categorized into the following segments:
- Oral drugs
- Topical drugs
- Others
Key Regions for the Erectile Dysfunction (ED) Drugs Market:
Featuring a breakdown of region-wise market shares until 2019.
- Asia
- Europe
- North America
- ROW
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
-
Market segmentation analysis
Market Sizing
- Market definition
-
Market size and forecast
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
Related Reports on Pharmaceuticals are:
Female Sexual Dysfunction Treatment Market – Global Female Sexual Dysfunction Treatment Market by type (non-hormonal therapy and hormonal therapy) and geography (Asia, Europe, North America, and ROW).
Sexual Enhancement Supplements Market– Global Sexual Enhancement Supplements Market by product (male sexual enhancement supplements and female sexual enhancement supplements), distribution channel (online stores and retail stores), and geography (Asia, Europe, North America, and ROW).
About Technavio
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
